# A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

URL: https://www.renown.org/clinical-trials-directory/1002511525

Short Title: C6461016

Enrollment Status: Recruiting

NCT #: [NCT07392892](https://clinicaltrials.gov/study/NCT07392892)

Specialty Area: Oncology

Condition Studied: Advanced or Metastatic Gastroesophageal Cancer

Age Groups: Adult; Older Adult

Sex: All

Study Type: Interventional

Accepts Healthy Volunteers: No

Phase: II/III

Principal Investigator: Harry Menon DO, MPH

Complete Study Details: https://clinicaltrials.gov/study/NCT07392892

## Study Information

### Summary / Purpose

The study is testing a new investigational medicine called PF-08634404, given through an IV, in combination with standard chemotherapy to see if this new combination can better treat advanced stomach cancer, cancer at the junction between the stomach and esophagus, or esophageal cancer that has either spread to other parts of the body or cannot be removed with surgery compared to current standard treatment options.

### Who Can Participate

- Adults 18+ years of age
- Have previously untreated, locally advanced or metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinoma that is HER2-negative and PD-L1 positive
- Have ECOG performance status of 0–1
- No active or untreated brain metastases
- No significant recent bleeding or cardiovascular events
- No serious uncontrolled medical conditions such as interstitial lung disease or autoimmune disease requiring treatment, or other conditions that would make participation unsafe.

### What's Involved

- Receiving PF-08634404 in combination with standard chemotherapy or a comparator treatment regimen administered in repeating cycles through intravenous (IV) infusions and/or orally.
- Attending regular clinic visits for safety monitoring, including physical exams, blood tests, and imaging scans to evaluate tumor response.

## Additional Information

Location: Renown Health, Office of Clinical Research

Address: 1500 E 2nd St. Reno, NV 89502

General Research: [775-982-3646](tel:775-982-3646)

Oncology Research: [775-982-5050](tel:775-982-5050)

Email: [Renown-CRD@renown.org](mailto:Renown-CRD@renown.org)
